Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Baxter International Inc.

https://www.baxter.com/

Latest From Baxter International Inc.

Hot Spots In 2023: US FDA Goal Dates Portend Battles In Diseases From RSV To Ulcerative Colitis

Novel agents targeting similar indications suggest potential commercial struggles across the therapeutic landscape, with battlegrounds taking shape between RSV vaccines, new mechanisms in major depression, and bispecifics for large B-cell lymphoma.

US FDA Performance Tracker Pink Sheet Perspectives

Behind A Rekindled Dream And China Biotech’s New Reality

The latest mega deals aimed at bringing Chinese innovation to the US have rekindled go-global hopes for a sector badly needing some cheer. But some investors say out-licensing may be the best route and that Chinese biotech must scale back its do-all mentality and focus on what it does best amid a new reality.

China Deals

Fresenius Kabi And Formycon Ally On Stelara Rival

Fresenius Kabi and Formycon have announced a global licensing deal for the FYB202 ustekinumab proposed biosimilar rival to Stelara. The deal comes as Formycon has revealed plans to raise further funds to funnel into research and development through a fresh share issue.

Deals Biosimilars

From Science To Commercialization: How Genexine Is Making The Shift

Genexine CEO Neil Warma talks to Scrip in this audio interview about a wide range of topics, including key strategy changes, ambitions to become a leading global biopharma, as well as challenges he has faced since joining the Korean biotech.

South Korea ImmunoOncology
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Medical Devices
  • Pharmaceuticals
  • Services
  • Pharmaceuticals
    • Drug Delivery
    • Nutraceuticals
  • Medical Devices
    • Infusion Therapy Equipment and Supplies
    • Surgical Equipment & Devices
      • Surgical Sealants
  • Other Names / Subsidiaries
    • AesRX LLC
    • Althin Medical A.B.
    • Chatham Therapeutics
    • Cheetah Medical
    • Claris Injectables Limited
    • Fusion Medical Technologies, Inc.
    • Gambro AB
    • Immuno-US
    • Prism Pharmaceuticals, Inc.
    • Renal Therapy Services
    • SIGMA International Geneeral Medical Apparatus
    • SuppreMol GmbH
    • Synovis Life Technologies, Inc.
    • Wound Care Technologies, Inc.
    • Baxter Healthcare Corporation
UsernamePublicRestriction

Register